Olaparib in BRCA+ Pancreatic Cancer: Cost-effectiveness Analyzed ...Middle East

Medscape - News
Maintenance therapy with olaparib is potentially a cost-effective option in this setting, but this could be improved by tailoring treatment based on individual patient factors. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Olaparib in BRCA+ Pancreatic Cancer: Cost-effectiveness Analyzed )

Apple Storegoogle play

Also on site :

Most viewed in News